Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-25-059562
Filing Date
2025-04-29
Accepted
2025-04-29 07:15:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A qttb_2025_defa_14a.htm DEFA14A 32547
2 GRAPHIC img155798123_0.jpg GRAPHIC 494163
3 GRAPHIC img155798123_1.jpg GRAPHIC 909387
  Complete submission text file 0000950170-25-059562.txt   1966144
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38433 | Film No.: 25882645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)